Utilization Pattern of Prescription Pain Medication Among Adults With Diabetes Mellitus

Abstract

20-year treatment success using ARBs relative to ACEIs. ConClusions: Management of the diabetic nephropathy from the earliest stage (microalbuminuria) using ARBs is the cost-effective strategy to reduce death and end-stage kidney disease for individuals with diabetes and microalbuminuria if they do not have contraindications.